Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hanjing Zhou

Showing results (31-40 of 32) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 32 results.
American Journal of Respiratory and Critical Care Medicine|July 29, 2025
Treatment with Allogenic Mesenchymal Stromal Cells for Moderate to Severe Acute Respiratory Distress Syndrome: A Double-Blind, Placebo-controlled, Multi-Center, Phase 2b Clinical Trial (STAT)Michael A Matthay, Hanjing Zhou, Aartik Sarma, et al.
American Journal of Respiratory and Critical Care Medicine|September 25, 2025
Acute Respiratory Distress Syndrome Molecular Phenotypes Have Distinct Lower Respiratory Tract TranscriptomesAartik Sarma, Stephanie A Christenson, Beth Zha Shoshana, et al.
Pageof 4

Showing results (31-40 of 32) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 32 results.
American Journal of Respiratory and Critical Care Medicine|July 29, 2025
Treatment with Allogenic Mesenchymal Stromal Cells for Moderate to Severe Acute Respiratory Distress Syndrome: A Double-Blind, Placebo-controlled, Multi-Center, Phase 2b Clinical Trial (STAT)Michael A Matthay, Hanjing Zhou, Aartik Sarma, et al.
American Journal of Respiratory and Critical Care Medicine|September 25, 2025
Acute Respiratory Distress Syndrome Molecular Phenotypes Have Distinct Lower Respiratory Tract TranscriptomesAartik Sarma, Stephanie A Christenson, Beth Zha Shoshana, et al.
Pageof 4